
Bruker Corporation BRKR
$ 58.22
7.04%
Quarterly report 2026-Q1
added 05-07-2026
Bruker Corporation Cash and Cash Equivalents 2011-2026 | BRKR
Annual Cash and Cash Equivalents Bruker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 299 M | 183 M | 488 M | 646 M | 1.07 B | 682 M | 678 M | 322 M | 325 M | 342 M | 267 M | 320 M | 439 M | 311 M | 246 M | 230 M | 207 M | 166 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.07 B | 166 M | 401 M |
Quarterly Cash and Cash Equivalents Bruker Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 133 M | 293 M | 92 M | 184 M | 183 M | 152 M | 170 M | 343 M | 488 M | 367 M | 578 M | 598 M | 646 M | 629 M | 726 M | 820 M | 1.07 B | 576 M | 608 M | 697 M | 682 M | 682 M | 682 M | 682 M | 678 M | 678 M | 678 M | 678 M | 322 M | 322 M | 322 M | 322 M | 325 M | 325 M | 325 M | 325 M | 342 M | 342 M | 342 M | 342 M | 267 M | 267 M | 267 M | 267 M | 320 M | 320 M | 320 M | 320 M | 439 M | 439 M | 439 M | 439 M | 311 M | 311 M | 311 M | 311 M | 246 M | 246 M | 246 M | 246 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.07 B | 92 M | 418 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
105 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
45.9 M | $ 12.51 | 2.21 % | $ 354 M | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
161 M | $ 7.93 | 0.51 % | $ 1.19 B | ||
|
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
29.8 M | $ 4.37 | 4.0 % | $ 164 M | ||
|
BioSig Technologies
BSGM
|
20.3 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | ||
|
IRIDEX Corporation
IRIX
|
6.03 M | $ 1.02 | -0.97 % | $ 17.3 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
7.28 M | $ 1.93 | -5.61 % | $ 42.6 M | ||
|
Cytosorbents Corporation
CTSO
|
6.25 M | $ 0.49 | -0.48 % | $ 30.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 17.47 | -1.91 % | $ 410 M | ||
|
LENSAR
LNSR
|
13 M | $ 5.88 | -2.08 % | $ 70.3 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 10.74 | -1.92 % | $ 385 M | ||
|
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.66 | -1.19 % | $ 67.5 M | ||
|
LivaNova PLC
LIVN
|
636 M | $ 73.76 | 0.98 % | $ 4.02 B | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Myomo
MYO
|
14.1 M | $ 1.08 | -1.38 % | $ 45.2 M | ||
|
MiMedx Group
MDXG
|
166 M | $ 3.71 | 1.09 % | $ 548 M | ||
|
Electromed
ELMD
|
15.3 M | $ 38.38 | -2.32 % | $ 324 M | ||
|
Orthofix Medical
OFIX
|
82 M | $ 9.45 | -0.42 % | $ 374 M | ||
|
Butterfly Network
BFLY
|
150 M | $ 4.43 | -4.01 % | $ 1.09 B | ||
|
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | ||
|
Profound Medical Corp.
PROF
|
59.7 M | $ 6.82 | -1.09 % | $ 206 M | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
526 M | $ 82.08 | -0.46 % | $ 11.1 B | ||
|
Insulet Corporation
PODD
|
716 M | $ 142.92 | 0.19 % | $ 10.1 B | ||
|
Sintx Technologies
SINT
|
4.14 M | $ 2.23 | 1.14 % | $ 6.18 M | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 35.78 | 1.02 % | $ 1.11 B | ||
|
Inspire Medical Systems
INSP
|
105 M | $ 42.81 | -0.67 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
17.2 M | $ 90.22 | 0.21 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.94 B | $ 86.14 | 0.22 % | $ 50.4 B | ||
|
TransMedics Group
TMDX
|
488 M | $ 68.4 | 0.84 % | $ 2.33 B |